Open access · CC-BY
via OpenAlex
Gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
Sherlyn Jemimah, Chahd Chabib, Leontios J. Hadjileontiadis, Aamna Al Shehhi
PLoS ONE · 2023 · ▲ 134 citations
Abstract
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder that causes gradual memory loss. AD and its prodromal stage of mild cognitive impairment (MCI) are marked by significant gut microbiome perturbations, also known as gut dysbiosis. However, the direction and extent of gut dysbiosis have not been elucidated. Therefore, we performed a meta-analysis and systematic review of 16S gut microbiome studies to gain insights into gut dysbiosis in AD and MCI. METHODS: We searched MEDLINE, Scopus, EMBASE, EBSCO, and Cochrane for AD gut microbiome studies published between Jan 1, 2010 and Mar 31, 2022. This study has two outcomes: primary and secondary. The primary outcomes explored the changes in α-diversity and relative abundance of microbial taxa, which were analyzed using a variance-weighted random-effects model. The secondary outcomes focused on qualitatively summarized β-diversity ordination and linear discriminant analysis effect sizes. The risk of bias was assessed using a methodology appropriate for the included case-control studies. The geographic cohorts' heterogeneity was examined using subgroup meta-analyses if sufficient studies reported the outcome. The study protocol has been registered with PROSPERO (CRD42022328141). FINDINGS: Seventeen studies with 679 AD and MCI patients and 632 controls were identified and analyzed. The cohort is 61.9% female with a mean age of 71.3±6.9 years. The meta-analysis shows an overall decrease in species richness in the AD gut microbiome. However, the phylum Bacteroides is consistently higher in US cohorts (standardised mean difference [SMD] 0.75, 95% confidence interval [CI] 0.37 to 1.13, p < 0.01) and lower in Chinese cohorts (SMD -0.79, 95% CI -1.32 to -0.25, p < 0.01). Moreover, the Phascolarctobacterium genus is shown to increase significantly, but only during the MCI stage. DISCUSSION: Notwithstanding possible confounding from polypharmacy, our findings show the relevance of diet and lifestyle in AD pathophysiology. Our study presents evidence for region-specific changes in abundance of Bacteroides, a major constituent of the microbiome. Moreover, the increase in Phascolarctobacterium and the decrease in Bacteroides in MCI subjects shows that gut microbiome dysbiosis is initiated in the prodromal stage. Therefore, studies of the gut microbiome can facilitate early diagnosis and intervention in Alzheimer's disease and perhaps other neurodegenerative disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0285346
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Jemimah, S., Chabib, C., Hadjileontiadis, L.J., & Shehhi, A.A. (2023). Gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0285346
Vancouver
Jemimah S, Chabib C, Hadjileontiadis LJ, Shehhi AA. Gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis. PLoS ONE. 2023. doi:10.1371/journal.pone.0285346.
BibTeX
@article{sherlyn2023Gutmic,
title = {Gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis},
author = {Sherlyn Jemimah and Chahd Chabib and Leontios J. Hadjileontiadis and Aamna Al Shehhi},
journal = {PLoS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285346},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2026
Citation only
Gut Dysbiosis in Alzheimer’s Disease: Insights from the Microbiome
Journal of Alzheimer s Disease 2021
Citation only
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer’s Disease or Mild Cognitive Impairment
Experimental Gerontology 2024
Open access · CC-BY
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Gut Microbes 2021
Open access · CC-BY
Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis
Frontiers in Cellular and Infection Microbiology 2020
Open access · CC-BY
The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer's Disease
University Hospital, Lille 2025
Open access · US-GOV